JP2014500867A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500867A5 JP2014500867A5 JP2013537678A JP2013537678A JP2014500867A5 JP 2014500867 A5 JP2014500867 A5 JP 2014500867A5 JP 2013537678 A JP2013537678 A JP 2013537678A JP 2013537678 A JP2013537678 A JP 2013537678A JP 2014500867 A5 JP2014500867 A5 JP 2014500867A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- active substance
- composition
- seq
- active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41188410P | 2010-11-09 | 2010-11-09 | |
| US61/411,884 | 2010-11-09 | ||
| US201161527574P | 2011-08-25 | 2011-08-25 | |
| US61/527,574 | 2011-08-25 | ||
| US201161528036P | 2011-08-26 | 2011-08-26 | |
| US61/528,036 | 2011-08-26 | ||
| PCT/US2011/054967 WO2012064429A2 (en) | 2010-11-09 | 2011-10-05 | Skin permeating and cell entering (space) peptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014500867A JP2014500867A (ja) | 2014-01-16 |
| JP2014500867A5 true JP2014500867A5 (cg-RX-API-DMAC7.html) | 2014-11-20 |
Family
ID=46051476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537678A Pending JP2014500867A (ja) | 2010-11-09 | 2011-10-05 | 皮膚浸透性および細胞侵入性(space)ペプチドとその使用法 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US8518871B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2638162B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014500867A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20130139254A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103201386A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011326732B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2811113A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012064429A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8834423B2 (en) | 2009-10-23 | 2014-09-16 | University of Pittsburgh—of the Commonwealth System of Higher Education | Dissolvable microneedle arrays for transdermal delivery to human skin |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2857499A1 (en) | 2010-10-01 | 2015-04-08 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| KR20130139254A (ko) | 2010-11-09 | 2013-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 피부 침투 및 세포 진입(space) 펩타이드 및 그의 사용방법 |
| CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| PT3682905T (pt) | 2011-10-03 | 2022-04-07 | Modernatx Inc | Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações |
| ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
| WO2013112488A2 (en) * | 2012-01-23 | 2013-08-01 | Kythera Biopharmaceuticals, Inc. | Dermal filling compositions and methods |
| WO2013151664A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US10501512B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides |
| EP4112112A1 (en) | 2012-05-01 | 2023-01-04 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Tip-loaded microneedle arrays for transdermal insertion |
| WO2013173307A1 (en) * | 2012-05-16 | 2013-11-21 | Neil Desai | Multi-target modulation for treating fibrosis and inflammatory conditions |
| KR101329411B1 (ko) * | 2012-05-31 | 2013-11-14 | 주식회사 엘지생활건강 | 피부투과성 펩타이드 |
| PT2922554T (pt) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Arn modificado nas porções terminais |
| CN103897043A (zh) * | 2012-12-28 | 2014-07-02 | 天津药物研究院 | 一种穿膜多肽连接拉帕替尼的制备及应用 |
| WO2014123543A2 (en) * | 2013-02-11 | 2014-08-14 | Convoy Therapeutics | Skin permeating and cell entering (space) peptides and methods of use therefor |
| US20140227174A1 (en) * | 2013-02-11 | 2014-08-14 | The Regents Of The University Of California | Skin permeating and cell entering (space) peptides and methods of use therefor |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| WO2015023649A2 (en) * | 2013-08-12 | 2015-02-19 | 3M Innovative Properties Company | Peptides for enhancing transdermal delivery |
| US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| KR101608131B1 (ko) * | 2013-11-14 | 2016-03-31 | 주식회사 엘지생활건강 | 인간 성장호르몬의 융합단백질을 포함하는 피부개선용 화장료 조성물 |
| US9321821B2 (en) | 2013-11-14 | 2016-04-26 | Lg Household & Health Care Ltd. | Cosmetic composition for improving skin conditions comprising fusion protein |
| WO2016033314A1 (en) * | 2014-08-27 | 2016-03-03 | The Regents Of The University Of California | Skin penetrating peptides (spps) and methods of use therefor |
| EP3197920B1 (en) * | 2014-09-25 | 2021-01-13 | Nanyang Technological University | Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages |
| WO2016071814A1 (en) | 2014-11-04 | 2016-05-12 | Università Degli Studi Di Milano | A promoter for cutaneous absorption of active ingredients having peptidic structure |
| WO2016149673A1 (en) | 2015-03-18 | 2016-09-22 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bioactive components conjugated to substrates of microneedle arrays |
| CN108350030B (zh) * | 2015-09-10 | 2022-12-13 | 汉阳大学校产学协力团 | 皮肤可渗透肽及其使用方法 |
| WO2017043920A1 (ko) * | 2015-09-10 | 2017-03-16 | 한양대학교 산학협력단 | 피부 투과성 펩티드 및 그 이용방법 |
| US20180251495A1 (en) * | 2015-09-15 | 2018-09-06 | The Regents Of The University Of California | Skin-Penetrating Peptides and Compositions and Methods of Use Thereof |
| US11684763B2 (en) | 2015-10-16 | 2023-06-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Multi-component bio-active drug delivery and controlled release to the skin by microneedle array devices |
| EP3369816B1 (en) * | 2015-10-30 | 2024-03-13 | Toray Industries, Inc. | Composition stably containing single-stranded nucleic acid molecule that suppresses expression of tgf-beta1 gene |
| WO2017082690A1 (ko) * | 2015-11-12 | 2017-05-18 | 주식회사 펩트론 | 미백, 피부 탄력, 주름 개선 및 상처치유 활성을 갖는 다기능성 피부투과 펩타이드 |
| US11744889B2 (en) | 2016-01-05 | 2023-09-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | Skin microenvironment targeted delivery for promoting immune and other responses |
| CN105504066A (zh) * | 2016-01-16 | 2016-04-20 | 广州市科玮生物技术有限公司 | 一种融合蛋白在化妆品中的应用 |
| JP2019502764A (ja) * | 2016-01-23 | 2019-01-31 | アンパサンド バイオファーマシューティカルズ インコーポレイテッドAmpersand Biopharmaceuticals Inc. | 活性薬剤の増強された経皮送達 |
| CA3087881A1 (en) | 2017-01-17 | 2018-07-26 | Michael David FORREST | Therapeutic inhibitors of the reverse mode of atp synthase |
| WO2018195111A1 (en) * | 2017-04-17 | 2018-10-25 | Ampersand Biopharmaceuticals, Llc | Parenteral non-systemic administration of buffering agents for inhibiting metastasis of solid tumors, hyperpigmentation and gout |
| KR102083978B1 (ko) * | 2017-12-18 | 2020-03-03 | 주식회사 엘지생활건강 | 혈소판유래 성장인자 a서브유닛의 융합 단백질을 포함하는 피부개선용 화장료 조성물 |
| KR102083976B1 (ko) * | 2017-12-18 | 2020-03-03 | 주식회사 엘지생활건강 | 혈관내피세포 성장인자의 융합 단백질을 포함하는 피부개선용 화장료 조성물 |
| CA3099077A1 (en) | 2017-07-13 | 2019-01-17 | Michael David FORREST | Therapeutic modulators of the reverse mode of atp synthase |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| EP4324460A3 (en) | 2017-09-15 | 2024-04-24 | Dyve Biosciences, Inc. | Sodium bicarbonate for use in the treatment of gout and related disorders |
| US10905738B2 (en) | 2018-07-05 | 2021-02-02 | Biozeus Desenvolvimento De Produtos Biofarmacêuticos | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
| WO2020214889A1 (en) | 2019-04-19 | 2020-10-22 | Fount Bio, Inc. | Delivery and retention of active agents within the skin |
| JP2022532215A (ja) | 2019-05-16 | 2022-07-13 | ユニバーシティ オブ ピッツバーグ - オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 皮膚および非皮膚薬物送達のためのアンダーカット特徴を有するマイクロニードルアレイ |
| WO2021113410A1 (en) * | 2019-12-02 | 2021-06-10 | Ampersand Biopharmaceuticals, Inc. | Transdermal penetrant formulations for vitamins, minerals and supplements |
| KR102301572B1 (ko) * | 2020-02-06 | 2021-09-10 | 인천대학교 산학협력단 | 신규한 핵산 분자 전달용 조성물 및 그 용도 |
| CN113943778A (zh) * | 2020-07-17 | 2022-01-18 | 通用电气医疗集团股份有限公司 | 用于核酸检测的分子探针及其制备方法和用途 |
| CN111803652B (zh) * | 2020-08-04 | 2021-09-14 | 南通康是美生物科技有限公司 | 治疗痤疮的化合物在制备治疗痤疮的药物组合物或化妆品组合物中的用途 |
| US20250325469A1 (en) | 2021-01-24 | 2025-10-23 | Michael David FORREST | Inhibitors of atp synthase - cosmetic and therapeutic uses |
| CN114315960B (zh) * | 2021-12-31 | 2022-10-14 | 深圳市维琪医药研发有限公司 | 一种经修饰的肽及其美容组合物或药用组合物和用途 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH624011A5 (cg-RX-API-DMAC7.html) | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
| US5077057A (en) | 1989-04-05 | 1991-12-31 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
| US6083539A (en) | 1994-12-16 | 2000-07-04 | Sakuma Ebisu Kabushiki Kaisha | Buckwheat starch syrup, method for preparing the same, and foods containing the same |
| US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| US20090070897A1 (en) | 2006-01-12 | 2009-03-12 | Goldman Barry S | Genes and uses for plant improvement |
| JP4596391B2 (ja) * | 2005-02-10 | 2010-12-08 | 国立大学法人大阪大学 | 細胞透過性ペプチド |
| US7659252B2 (en) | 2005-09-15 | 2010-02-09 | Novomed Technologies, Inc. (Shanghai) | Transdermal delivery peptides and method of use thereof |
| WO2007035474A2 (en) | 2005-09-15 | 2007-03-29 | Novomed Technologies, Inc. (Shanghai) | Transdermal delivery peptides and method of use thereof |
| JP2007143454A (ja) * | 2005-11-25 | 2007-06-14 | Toray Ind Inc | 細胞膜通過性ペプチド |
| EP1968643A2 (en) * | 2005-12-16 | 2008-09-17 | Diatos | Cell penetrating peptide conjugates for delivering of nucleic acids into a cell |
| GB0606415D0 (en) | 2006-03-31 | 2006-05-10 | Univ Southampton | Topical drug delivery |
| WO2008073856A2 (en) | 2006-12-08 | 2008-06-19 | Massachusetts Institute Of Technology | Delivery of nanoparticles and/or agents to cells |
| JP2008200011A (ja) * | 2007-02-22 | 2008-09-04 | Toray Ind Inc | 細胞内移行性ペプチド、それを含有する医薬組成物及びその使用方法 |
| WO2009032148A1 (en) | 2007-08-29 | 2009-03-12 | Tufts University | Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
| WO2010039088A1 (en) * | 2008-09-16 | 2010-04-08 | Kariem Ahmed | Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| US8389481B2 (en) * | 2008-11-12 | 2013-03-05 | University Of Medicine And Dentistry Of New Jersey | Glutamate-enhanced cell-penetrating peptides and methods of using same |
| CN101812439B (zh) * | 2009-02-25 | 2012-07-04 | 张舒羽 | 一种透皮结构域及其衍生的具有透皮作用的融合蛋白和其制备方法 |
| EP2421505A4 (en) * | 2009-04-22 | 2014-01-01 | Univ Texas | HYDROGELES FOR THE COMBINATORY RELEASE OF IMMUNOMODULATING BIOMOLECULES |
| WO2010129023A2 (en) | 2009-04-28 | 2010-11-11 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
| KR20130139254A (ko) | 2010-11-09 | 2013-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 피부 침투 및 세포 진입(space) 펩타이드 및 그의 사용방법 |
| CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
-
2011
- 2011-10-05 KR KR1020137008413A patent/KR20130139254A/ko not_active Withdrawn
- 2011-10-05 CA CA2811113A patent/CA2811113A1/en not_active Abandoned
- 2011-10-05 EP EP11839394.1A patent/EP2638162B1/en not_active Not-in-force
- 2011-10-05 JP JP2013537678A patent/JP2014500867A/ja active Pending
- 2011-10-05 US US13/253,796 patent/US8518871B2/en active Active
- 2011-10-05 CN CN2011800532510A patent/CN103201386A/zh active Pending
- 2011-10-05 WO PCT/US2011/054967 patent/WO2012064429A2/en not_active Ceased
- 2011-10-05 AU AU2011326732A patent/AU2011326732B2/en not_active Expired - Fee Related
-
2013
- 2013-07-26 US US13/952,525 patent/US8791062B2/en active Active
-
2014
- 2014-04-25 US US14/262,453 patent/US9441014B2/en active Active
-
2016
- 2016-08-04 US US15/228,852 patent/US20170173173A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Recruiting T‐cells toward the brain for enhanced glioblastoma immunotherapeutic efficacy by co‐delivery of cytokines and immune checkpoint antibodies with macrophage‐membrane‐camouflaged nanovesicles | |
| Peng et al. | DNA nanostructure-programmed cell entry via corner angle-mediated molecular interaction with membrane receptors | |
| Zhao et al. | Integrin-targeting peptides for the design of functional cell-responsive biomaterials | |
| He et al. | Synthetic charge-invertible polymer for rapid and complete implantation of layer-by-layer microneedle drug films for enhanced transdermal vaccination | |
| Davis | The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic | |
| Winblade et al. | Blocking Adhesion to Cell and Tissue Surfaces by the Chemisorption of a Poly-l-lysine-g raft-(poly (ethylene glycol); phenylboronic acid) Copolymer | |
| Boraschi et al. | Interaction of nanoparticles with immunocompetent cells: nanosafety considerations | |
| Liu et al. | Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo | |
| Robison et al. | Polyarginine interacts more strongly and cooperatively than polylysine with phospholipid bilayers | |
| US9642895B2 (en) | Peptides for enhancing transdermal delivery | |
| CN104271149B (zh) | 经皮递送装置 | |
| Han et al. | Zwitterlation mitigates protein bioactivity loss in vitro over PEGylation | |
| Wahlich et al. | Nanomedicines for the Delivery of Biologics | |
| Wender et al. | Dendrimeric molecular transporters: synthesis and evaluation of tunable polyguanidino dendrimers that facilitate cellular uptake | |
| Zhang et al. | Novel pharmaceutical strategies for enhancing skin penetration of biomacromolecules | |
| JP2009526754A5 (cg-RX-API-DMAC7.html) | ||
| Srivatsav et al. | The emerging world of membrane vesicles: functional relevance, theranostic avenues and tools for investigating membrane function | |
| JP2006523453A5 (cg-RX-API-DMAC7.html) | ||
| Gao et al. | Bacteria-mediated intracellular click reaction for drug enrichment and selective apoptosis of drug-resistant tumor cells | |
| Li et al. | Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide | |
| Huang et al. | Acidic microenvironment triggered in situ assembly of activatable three-arm aptamer nanoclaw for contrast-enhanced imaging and tumor growth inhibition in vivo | |
| Upadhyay et al. | Recent advancement in SARS-CoV-2 diagnosis, treatment, and vaccine formulation: a new paradigm of nanotechnology in strategic combating of COVID-19 pandemic | |
| Wei et al. | Hepatocyte-targeted delivery using oleanolic acid-loaded liposomes for enhanced hepatocellular carcinoma therapy | |
| Shi et al. | Advances in nanotherapy for targeting senescent cells | |
| Jasiewicz et al. | ZipperCells exhibit enhanced accumulation and retention at the site of myocardial infarction |